Ozzy Osbourne will come out of touring retirement and reunite with the full Black Sabbath lineup for the first time in 20 ...

Heavy metal star Ozzy Osbourne reveals the date for his final show, which will also reunite the founding members of Black ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...

Mick Broad has taken part in research by Manchester's Royal Northern School of Music (RNCM) into the way music can support ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...

A new study published in the Journal of Medical Internet Research has found that regular participation in dance classes can ...

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's ...

Sharon Osbourne gave an update on how Parkinson’s disease has impacted husband Ozzy Osbourne’s legs as the musician prepares ...

Richard Balanson says when one suffers a disease "you begin to accumulate friends" who have their own story with the same ...